<VariationArchive RecordType="classified" VariationID="8628" VariationName="NM_020547.3(AMHR2):c.596del (p.Glu199fs)" VariationType="Deletion" Accession="VCV000008628" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23667" VariationID="8628">
      <GeneList>
        <Gene Symbol="AMHR2" FullName="anti-Mullerian hormone receptor type 2" GeneID="269" HGNC_ID="HGNC:465" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="53423855" stop="53431672" display_start="53423855" display_stop="53431672" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="53817638" stop="53825317" display_start="53817638" display_stop="53825317" Strand="+" />
          </Location>
          <OMIM>600956</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020547.3(AMHR2):c.596del (p.Glu199fs)</Name>
      <CanonicalSPDI>NC_000012.12:53425547:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="53425548" stop="53425548" display_start="53425548" display_stop="53425548" variantLength="1" positionVCF="53425547" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="53819332" stop="53819332" display_start="53819332" display_stop="53819332" variantLength="1" positionVCF="53819331" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E199fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.53819332del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.53819332del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.53425548del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.53425548del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015981.1" sequenceAccession="NG_015981" sequenceVersion="1" change="g.6694del">
            <Expression>NG_015981.1:g.6694del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164690.2" sequenceAccession="NM_001164690" sequenceVersion="2" change="c.596del">
            <Expression>NM_001164690.2:c.596del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158162.1" sequenceAccession="NP_001158162" sequenceVersion="1" change="p.Glu199fs">
            <Expression>NP_001158162.1:p.Glu199fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164691.2" sequenceAccession="NM_001164691" sequenceVersion="2" change="c.596del">
            <Expression>NM_001164691.2:c.596del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158163.1" sequenceAccession="NP_001158163" sequenceVersion="1" change="p.Glu199fs">
            <Expression>NP_001158163.1:p.Glu199fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020547.3" sequenceAccession="NM_020547" sequenceVersion="3" change="c.596del" MANESelect="true">
            <Expression>NM_020547.3:c.596del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065434.1" sequenceAccession="NP_065434" sequenceVersion="1" change="p.Glu199fs">
            <Expression>NP_065434.1:p.Glu199fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1939497801" DB="dbSNP" />
        <XRef Type="Allelic variant" ID="600956.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 600956.0003 from the sequence reported in Figure 2 of the paper by Messika-Zeitoun et al., 2001 (PubMed 11549681).</Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020547.3(AMHR2):c.596del (p.Glu199fs) AND Persistent mullerian duct syndrome, type II" Accession="RCV000009160" Version="2">
        <ClassifiedConditionList TraitSetID="2370">
          <ClassifiedCondition DB="MedGen" ID="C3897940">Persistent mullerian duct syndrome, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11549681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19457927</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2370" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10460" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Persistent mullerian duct syndrome, type II</ElementValue>
              </Name>
              <XRef ID="C3897940" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29377" SubmissionDate="2010-07-16" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600956.0003_PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II" title="AMHR2, 1-BP DEL, 1692A _PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II" />
        <ClinVarAccession Accession="SCV000029377" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-08-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with 2 members with persistent mullerian duct syndrome (261550) and one normal sib, Messika-Zeitoun et al. (2001) detected 2 novel mutations of the AMHR2 gene. One, transmitted by the mother to her 3 sons, was a deletion of an adenosine at nucleotide position 1692 in exon 5, leading to a stop codon and causing receptor truncation after the transmembrane domain. The other, a missense mutation in the substrate-binding site of the kinase domain (600956.0004), was transmitted by the father to the 2 affected sons, indicating a recessive autosomal transmission as in other cases of persistent mullerian duct syndrome. Truncating mutations in receptors of the TGF-beta family exert dominant-negative activity, which was seen only when each of the mutant anti-mullerian hormone receptors was overexpressed in an anti-mullerian hormone-responsive cell line. The authors concluded that assessment of dominant activity in vitro, which usually involves overexpression of mutant genes, does not necessarily produce information applicable to clinical conditions, in which mutant and endogenous genes are expressed on a one-to-one basis.</Attribute>
              <Citation>
                <ID Source="PubMed">11549681</ID>
              </Citation>
              <XRef DB="OMIM" ID="261550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Belville et al. (2009) noted that the 1692delA mutation lacks the entire kinase domain and is therefore incapable of transducing an AMH signal.</Attribute>
              <Citation>
                <ID Source="PubMed">19457927</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AMHR2" />
          </GeneList>
          <Name>AMHR2, 1-BP DEL, 1692A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1692A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600956.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29377" TraitType="Disease" MappingType="Name" MappingValue="PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C3897940" Name="Persistent mullerian duct syndrome, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

